Allspring Global Investments’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42M Sell
184,224
-3,418
-2% -$766K 0.07% 326
2025
Q4
$40M Sell
187,642
-4,030
-2% -$832K 0.06% 350
2025
Q3
$39.1M Sell
191,672
-8,585
-4% -$1.6M 0.06% 359
2025
Q2
$34.4M Buy
200,257
+10,644
+6% +$1.73M 0.06% 380
2025
Q1
$28.7M Buy
189,613
+36,875
+24% +$5.27M 0.05% 429
2024
Q4
$21.1M Sell
152,738
-8,672
-5% -$1.14M 0.03% 520
2024
Q3
$24.1M Sell
161,410
-17,842
-10% -$2.41M 0.04% 510
2024
Q2
$24.4M Sell
179,252
-9,956
-5% -$1.35M 0.04% 499
2024
Q1
$28.6M Sell
189,208
-13,964
-7% -$1.99M 0.04% 475
2023
Q4
$25.6M Sell
203,172
-9,823
-5% -$979K 0.04% 491
2023
Q3
$19.9M Sell
212,995
-11,524
-5% -$1.08M 0.04% 556
2023
Q2
$20M Sell
224,519
-15,696
-7% -$1.37M 0.03% 597
2023
Q1
$25.8M Sell
240,215
-10,355
-4% -$1.18M 0.04% 512
2022
Q4
$30.6M Sell
250,570
-5,358
-2% -$622K 0.05% 455
2022
Q3
$26.4M Sell
255,928
-7,781
-3% -$738K 0.05% 487
2022
Q2
$24.5M Sell
263,709
-4,886
-2% -$460K 0.04% 519
2022
Q1
$31.5M Sell
268,595
-7,358
-3% -$852K 0.04% 517
2021
Q4
$37.1M Buy
+275,953
New +$41M 0.04% 526

Other funds holding ASND